Danny Dhanasekaran

Affiliations: 
Molecular Biology and Genetics Temple University, Philadelphia, PA, United States 
Area:
Molecular Biology
Google:
"Danny Dhanasekaran"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gunderson CC, Radhakrishnan R, Gomathinayagam R, et al. (2022) Circulating Tumor Cell-Free DNA Genes as Prognostic Gene Signature for Platinum Resistant Ovarian Cancer Diagnosis. Biomarker Insights. 17: 11772719221088404
Ferraresi A, Esposito A, Girone C, et al. (2021) Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy. Cells. 10
Ha JH, Jayaraman M, Yan M, et al. (2021) -Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer. Biomolecules. 11
Ha JH, Jayaraman M, Yan M, et al. (2021) Identification of -driven gene signatures and key signaling networks in ovarian cancer. Oncology Letters. 22: 719
Xiong X, Rao G, Roy RV, et al. (2020) Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology
Ha JH, Jayaraman M, Radhakrishnan R, et al. (2020) Differential effects of thymoquinone on lysophosphatidic acid-induced oncogenic pathways in ovarian cancer cells. Journal of Traditional and Complementary Medicine. 10: 207-216
Gunderson C, Evans E, Radhakrishnan R, et al. (2020) Circulating Tumor Cell-Free DNA Genes As Biomarkers For Platinum Resistant Ovarian Cancer Diagnosis Gynecologic Oncology. 156: e3-e4
Ha JH, Jayaraman M, Radhakrishnan R, et al. (2020) Differential effects of thymoquinone on lysophosphatidic acid-induced oncogenic pathways in ovarian cancer cells Journal of Traditional and Complementary Medicine. 10: 207-216
Radhakrishnan R, Ha JH, Jayaraman M, et al. (2018) Ovarian Cancer Cell-derived Lysophosphatidic Acid Induces Glycolytic Shift and Cancer-associated Fibroblast-Phenotype in Normal and Peritumoral Fibroblasts. Cancer Letters
Ha JH, Radhakrishnan R, Jayaraman M, et al. (2018) Lysophosphatidic Acid Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response. Cancer Research
See more...